✦ LIBER ✦

A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa

✍ Scribed by Godefridus J. Peters; Cees J. van Groeningen; Emile J. Laurensse; Herbert M. Pinedo

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 663 KB
Volume: 68
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19911101)68:9<1903::aid-cncr2820680910>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differences in metabolism of 5-fluoroura

Differences in metabolism of 5-fluorouracil and 5-fluorouridine and regulation by glucosamine in human colon cancer multicell tumor spheroids

✍ Tong-Bin Chen; Zěljko Bajzer; Slobodan Macura; Stanimir Vuk-Pavlović 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 2 views

## Glucosamine (GlcN) modulates fluoropyrimidine metabolism and enhances cytotoxicity of 5fluorouridine (FUrd), but not of 5-fluorouracil (FUra), in human tumor models. To elucidate the underlying metabolic differences between FUra and FUrd, by the use of 19 F and 31 P NMR spectroscopy we studied

Comparison of 5-fluorouracil with 5-fluo

Comparison of 5-fluorouracil with 5-fluorouracil, cyclophosphamide, and methotrexate in metastatic colorectal carcinoma

✍ Frederick Richards II; Thomas L. Pajak; Miles R. Cooper; Charles L. Spurr 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

Thirty-eight patients with metastatic colorecal carcinoma were treated with 5-fluorouracil (5-FU), and 38 patients were treated with the combination of 5-FU, cyclophosphamide, and methotrexate. In terms of percent response, response duration, and survival there was no apparent difference between the

Methyl-CCNU, 6-Thioguanine, and 5-fluoro

Methyl-CCNU, 6-Thioguanine, and 5-fluorouracil in advanced colorectal cancer

✍ Aroney, R. S. ;Dalley, D. N. ;Chan, W. K. ;Bell, D. R. ;Levi, J. A. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB

## Abstract Consecutive studies were undertaken in advanced colorectal adenocarcinoma, comparing two different schedules of the combination methyl‐CCNU, 6‐thioguanine, and 5‐fluorouracil in 89 patients. The two schedules exhibited similar efficacies, with a combined complete and partial remission r

LDH isoenzyme patterns in tumors, polyps

LDH isoenzyme patterns in tumors, polyps, and uninvolved mucosa of human cancerous colon

✍ P. Carda-Abella; S. Perez-Cuadrado; S. Lara-Baruque; L. Gil-Grande; A. Nuñez-Pue 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

Upregulation of glycolytic enzymes in pr

Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance

✍ Young-Kyoung Shin; Byong Chul Yoo; Yong Sang Hong; Hee Jin Chang; Kyung Hae Jung 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB

Prognostic impact of orotate phosphoribo

Prognostic impact of orotate phosphoribosyl transferase among 5-fluorouracil metabolic enzymes in resectable colorectal cancers treated by oral 5-fluorouracil-based adjuvant chemotherapy

✍ Takumi Ochiai; Kazuhiko Nishimura; Hajime Noguchi; Masayuki Kitajima; Akira Tsuk 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 160 KB

## Abstract Orotate phosphoribosyl transferase (OPRT) is the main enzyme that involves in phosphoribosylation of 5‐fluorouracil (5‐FU), an essential step that leads to tumor growth inhibition. In our study, the prognostic relevance of OPRT, thymidylate synthase (TS) and dihydropyrimidine dehydrogen